Title : The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.

Pub. Date : 2013 Jan-Mar

PMID : 23613396






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The purpose of this study was to investigate the predictive value of the presence of K-RAS and B-RAF mutations on the outcome of patients with mCRC treated with FOLFIRI and bevacizumab combination therapy. FOLFIRI regimen KRAS proto-oncogene, GTPase Homo sapiens
2 The purpose of this study was to investigate the predictive value of the presence of K-RAS and B-RAF mutations on the outcome of patients with mCRC treated with FOLFIRI and bevacizumab combination therapy. FOLFIRI regimen B-Raf proto-oncogene, serine/threonine kinase Homo sapiens